Invacare Reports Results For Third Quarter 2020.
Q3 ADJUSTED LOSS PER SHARE $0.10.
Q3 GAAP LOSS PER SHARE $0.21.
INCREASES FULL YEAR 2020 GUIDANCE FOR NET SALES AND ADJUSTED EBITDA.
SEES FY 2020 REPORTED NET SALES OF AT LEAST $840 MILLION, UP FROM PREVIOUS RANGE OF $810 TO $840 MILLION.
SEES FY 2020 ADJUSTED EBITDA IN THE RANGE OF $28 TO $32 MILLION, UP FROM PREVIOUS RANGE OF $27 TO $30 MILLION.
SEES FY 2020 FREE CASH FLOW USAGE IN THE RANGE OF $8 TO $12 MILLION, CHANGED FROM PREVIOUS RANGE OF $7 TO $10 MILLION.
